Nanorobotics in Healthcare Market: Current Analysis and Forecast (2023-2030)
Emphasis on Method of Preparation (Biochip, Nubots, Biohybrids, Bacteria-Base, Virus Based); Type (Pharmacyte, Diagnosis and Imaging, Respirocyte, Microbivores, Others); and Application (Nanorobotics In Surgery, Nanorobotics In Gene Therapy, Nanorobotics In Oncology, Nanorobotics In Dental, Others); and Region/Country
The nanorobotics in the healthcare market was valued at USD 7560.45 million in 2022 & expected to grow at a strong CAGR of around 12.24% during the forecast period (2023-2030) owing to the increase in the awareness of nanomedicine in the healthcare industry that drives the market. Moreover, nanorobotics in the healthcare market is expanding due to the increasing prevalence of chronic diseases and the growing advancements in molecular robots drive the growth of nanorobotics in healthcare by creating a greater demand for advanced treatment methods and oncology solutions. For instance, in August 2022, Novavax, Inc. announced that it applied to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its protein-based COVID-19 Vaccine, Adjuvanted for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a homologous and heterologous booster in adults aged 18 and older. Furthermore. Their derivatives further contribute to market growth during the forecast period.
Some of the major players operating in the market include Nanobiotix, Bruker, Novartis AG, Novavax, Nanoscribe GmbH & Co. KG, Siemens Healthcare GmbH, DNAe Group Holdings Ltd, Oxford Nanopore Technologies plc, Ocean NanoTech, Nanospectra Biosciences. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst method of preparation, nubots segment is expected to grow with a significant CAGR during the forecast period (2023-2030)”
Based on the methods of preparation, the market is segmented into biochip, nubots, biohybrids, bacteria-base, and virus-based. Amongst these, the nubots segment is expected to grow with a significant CAGR during the forecast period (2023-2030). This is the best possible way to facilitate the required manufacturing technology for nanorobots for universal medical applications, such as surgical instrumentation, diagnosis, and drug delivery. Therefore, practical nanorobots should be integrated as nanoelectronics devices, which will grant teleoperation and advanced capabilities for medical instrumentation.
“Amongst end-users, nanorobotics in the oncology segment held a significant share of the market in 2022.”
By application, the market is segmented into nanorobotics in surgery, nanorobotics in gene therapy, nanorobotics in oncology, nanorobotics in dental, and others. The nanorobotics in the oncology segment held a significant share of the market in 2022 due to the growing fungal infections in the oral cavity. Moreover, The World Health Organization has begun efforts to strengthen the global response to fungal infections and antifungal resistance due to the threat to global health. For instance, in May 2023, Specialists from Penn Dental and Penn Designing developed a new approach to eradicate fungal infections quickly and precisely in the mouth by utilizing nanorobots directed by magnets.
“Europe has extensive growth”
Europe is the second biggest market for nanorobotics, representing a critical portion of the worldwide nanorobotics in the healthcare market. This development is driven by the rising industries among European organizations to create nanorobots for malignant growth treatment applications. Adding to this, European businesses are making significant investments in research and development to develop new products that can make use of the distinctive characteristics of nanotechnology to improve patient outcomes. As per the European Commission, in October 2022, The EU-funded Phoenix project aims to facilitate the translation of nanopharmaceuticals from bench to bedside through the establishment of an open innovation test bed (OITB) that complies with regulatory and good manufacturing practice guidelines.
Nanorobotics in Healthcare Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global nanorobotics in healthcare market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Nanorobotics in Healthcare Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global nanorobotics in healthcare market were the three major steps undertaken to create and analyze the adoption of nanorobotics in healthcare in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global nanorobotics in healthcare market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the nanorobotics in healthcare market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the nanorobotics in healthcare market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as method of preparation, type, and application. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the nanorobotics in healthcare market. Further, we conducted factor analysis using dependent and independent variables such as method of preparation, type, and application of the nanorobotics in healthcare market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the nanorobotics in healthcare market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global nanorobotics in healthcare market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the nanorobotics in healthcare market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global nanorobotics in healthcare market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global nanorobotics in healthcare market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the method of preparation, type, and application in the global nanorobotics in healthcare market.
The main objective of the Global Nanorobotics in healthcare Market Study
The current & future market trends of the global nanorobotics in healthcare market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the nanorobotics in healthcare market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the method of preparation, type, and application
- Define and analysis of the regulatory framework for the nanorobotics in healthcare industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the nanorobotics in healthcare market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the nanorobotics in healthcare market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
